Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 146

PubMed (Weighted) Links for Nucleotide (Select 301500667)

1.

Acetylation regulates the stability of glutamate carboxypeptidase II protein in human astrocytes.

Choi JY, Kim JH, Jo SA.

Biochem Biophys Res Commun. 2014 Jul 18;450(1):372-7. doi: 10.1016/j.bbrc.2014.05.132. Epub 2014 Jun 2.

PMID:
24939622
2.

Insight into the heterogeneity of prostate cancer through PSA-PSMA prostate clones: mechanisms and consequences.

Ben Jemaa A, Bouraoui Y, Oueslati R.

Histol Histopathol. 2014 Oct;29(10):1263-80. Epub 2014 Apr 30. Review.

PMID:
24788382
3.

How prostate-specific membrane antigen level may be correlated with stemness in prostate cancer stem cell-like cell populations?

Maria T, Panagiotis A, Marina C, Eleni K, Ioanna V, Georgia M, Ioannis P.

J Cancer Res Ther. 2014 Jan-Mar;10(1):133-41. doi: 10.4103/0973-1482.131461.

4.

Prostate-specific membrane antigen as a marker of pancreatic cancer cells.

Ren H, Zhang H, Wang X, Liu J, Yuan Z, Hao J.

Med Oncol. 2014 Mar;31(3):857. doi: 10.1007/s12032-014-0857-z. Epub 2014 Jan 30.

PMID:
24477651
5.

Functional prostate-specific membrane antigen is enriched in exosomes from prostate cancer cells.

Liu T, Mendes DE, Berkman CE.

Int J Oncol. 2014 Mar;44(3):918-22. doi: 10.3892/ijo.2014.2256. Epub 2014 Jan 10.

6.

Prostate-specific membrane antigen expression in tumor-associated vasculature of breast cancers.

Wernicke AG, Varma S, Greenwood EA, Christos PJ, Chao KS, Liu H, Bander NH, Shin SJ.

APMIS. 2014 Jun;122(6):482-9. doi: 10.1111/apm.12195. Epub 2013 Dec 5.

PMID:
24304465
7.

Detection of pelvic lymph node micrometastasis by real-time reverse transcriptase polymerase chain reaction in prostate cancer patients after hormonal therapy.

Liu DY, Xia WM, Tang Q, Wang J, Wang MW, Wang Y, Wang SJ, Ye YF, Zhou WL, Shao Y.

J Cancer Res Clin Oncol. 2014 Feb;140(2):235-41. doi: 10.1007/s00432-013-1558-2. Epub 2013 Dec 1.

PMID:
24292502
8.

Prostate-specific membrane antigen protein expression in tumor tissue and risk of lethal prostate cancer.

Kasperzyk JL, Finn SP, Flavin R, Fiorentino M, Lis R, Hendrickson WK, Clinton SK, Sesso HD, Giovannucci EL, Stampfer MJ, Loda M, Mucci LA.

Cancer Epidemiol Biomarkers Prev. 2013 Dec;22(12):2354-63. doi: 10.1158/1055-9965.EPI-13-0668. Epub 2013 Oct 15.

9.

PSMA/PSA ratio evaluated by immunohistochemistry may improve diagnosis of prostate cancer.

Jemaa AB, Bouraoui Y, Sallami S, Banasr A, Nouira Y, Oueslati R.

J Immunoassay Immunochem. 2014;35(1):48-59. doi: 10.1080/15321819.2013.792830.

PMID:
24063616
10.

Preparation of asymmetric urea derivatives that target prostate-specific membrane antigen for SPECT imaging.

Harada N, Kimura H, Ono M, Saji H.

J Med Chem. 2013 Oct 24;56(20):7890-901. doi: 10.1021/jm400895s. Epub 2013 Oct 9.

PMID:
24063417
11.

A comparison of the biological features of prostate cancer with (PSA+, PSMA+) profile according to RKIP.

Ben Jemaa A, Bouraoui Y, Sallami S, Nouira Y, Oueslati R.

Biomed Res Int. 2013;2013:409179. doi: 10.1155/2013/409179. Epub 2013 Aug 7.

12.

GCPII modulates oxidative stress and prostate cancer susceptibility through changes in methylation of RASSF1, BNIP3, GSTP1 and Ec-SOD.

Divyya S, Naushad SM, Murthy PV, Reddy ChR, Kutala VK.

Mol Biol Rep. 2013 Oct;40(10):5541-50. doi: 10.1007/s11033-013-2655-7. Epub 2013 Aug 24.

PMID:
23979608
13.

S1 pocket of glutamate carboxypeptidase II: a new binding site for amyloid-β degradation.

Lee SK, Kim H, Cheong YH, Kim MJ, Jo SA, Youn HS, Park SI.

Biochem Biophys Res Commun. 2013 Sep 6;438(4):765-71. doi: 10.1016/j.bbrc.2013.07.059. Epub 2013 Jul 23.

PMID:
23891752
14.

Prostate specific membrane antigen produces pro-angiogenic laminin peptides downstream of matrix metalloprotease-2.

Conway RE, Joiner K, Patterson A, Bourgeois D, Rampp R, Hannah BC, McReynolds S, Elder JM, Gilfilen H, Shapiro LH.

Angiogenesis. 2013 Oct;16(4):847-60. doi: 10.1007/s10456-013-9360-y. Epub 2013 Jun 18.

PMID:
23775497
15.

In-depth proteomic analyses of exosomes isolated from expressed prostatic secretions in urine.

Principe S, Jones EE, Kim Y, Sinha A, Nyalwidhe JO, Brooks J, Semmes OJ, Troyer DA, Lance RS, Kislinger T, Drake RR.

Proteomics. 2013 May;13(10-11):1667-71. doi: 10.1002/pmic.201200561. Epub 2013 Apr 23.

16.

Glutamate carboxypeptidase II does not process amyloid-β peptide.

Sedlák F, Šácha P, Blechová M, Březinová A, Šafařík M, Šebestík J, Konvalinka J.

FASEB J. 2013 Jul;27(7):2626-32. doi: 10.1096/fj.12-225094. Epub 2013 Mar 23.

17.

Glutamate carboxypeptidase II is not an amyloid peptide-degrading enzyme.

Alt J, Stathis M, Rojas C, Slusher B.

FASEB J. 2013 Jul;27(7):2620-5. doi: 10.1096/fj.12-225102. Epub 2013 Mar 23.

18.

Randomized multicenter investigation of folate plus vitamin B12 supplementation in schizophrenia.

Roffman JL, Lamberti JS, Achtyes E, Macklin EA, Galendez GC, Raeke LH, Silverstein NJ, Smoller JW, Hill M, Goff DC.

JAMA Psychiatry. 2013 May;70(5):481-9. doi: 10.1001/jamapsychiatry.2013.900.

19.

Cloning and characterization of canine prostate-specific membrane antigen.

Schmidt S, Fracasso G, Colombatti M, Naim HY.

Prostate. 2013 May;73(6):642-50. doi: 10.1002/pros.22605. Epub 2013 Jan 28.

PMID:
23359458
20.

Association of glutamate carboxypeptidase II (GCPII) haplotypes with breast and prostate cancer risk.

Divyya S, Naushad SM, Addlagatta A, Murthy PV, Reddy ChR, Digumarti RR, Gottumukkala SR, Subbarao SA, Kutala VK.

Gene. 2013 Mar 1;516(1):76-81. doi: 10.1016/j.gene.2012.11.047. Epub 2012 Dec 22.

PMID:
23266799
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk